ebcc 8: triple negative advanced breast cancer treatment with parp inhibitors
Published 12 years ago • 188 plays • Length 1:02Download video MP4
Download video MP3
Similar videos
-
2:59
parp inhibitors for metastatic breast cancer
-
2:48
immunomodulatory effects of parp inhibition in brca1-deficient triple-negative breast cancer
-
1:10
managing metastatic breast cancer and beyond using parp inhibitors
-
1:06
ebcc 8: endocrine management of breast cancer and advanced breast cancer
-
3:58
parp inhibitors plus immunotherapy for advanced triple negative breast cancer
-
5:55
asco 2009: parp inhibitor bs-201 plus chemotherapy: new option for triple-negative breast cancer
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
3:04
advances in parp inhibitor use for metastatic breast cancer
-
6:19
chemosymposium 2011: parp treatment for brca mutated and triple negative breast cancer
-
9:32
brca mutation in metastatic tnbc patients
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
0:53
enhancing triple negative breast cancer treatment with immunotherapy across all settings
-
2:08
dr. lorusso on parp inhibitors in triple-negative breast cancer
-
8:08
parp inhibitors and carboplatin for neoadjuvant triple negative breast cancer treatment
-
2:15
parp inhibitors in metastatic breast cancer: where are we now?
-
3:32
dora: using olaparib alone or with durvalumab in platinum responsive advanced triple-negative br...
-
3:52
benefits and challenges of using parp inhibitors to treat metastatic breast cancer
-
8:55
survival outcomes from the calgb 40603 study in triple-negative breast cancer
-
5:19
parp inhibitors for brca-associated tnbc